Kortex Ventures

Kortex Ventures is a Brazilian venture capital firm specializing in early-stage investments within the healthcare and digital health sectors. The firm is dedicated to partnering with entrepreneurs and technology companies to drive innovation and transform the healthcare industry. They primarily focus on Series A funding rounds, though they also participate in Seed investments, supporting impactful healthtech solutions.

Founded in 2020, Kortex Ventures emerged from a strategic collaboration of three prominent Brazilian healthcare corporations: Grupo Fleury, Sabin, and Bradesco Saúde. Initially conceived as Fleury Ventures, the fund expanded its partnership in 2020 with the entry of Sabin, followed by Bradesco Saúde joining as a limited partner. This multi-LP structure allows Kortex Ventures to leverage a broad network and deep industry expertise from its corporate backers.

The firm's portfolio includes a range of innovative companies. Notable investments feature Welbe, which provides occupational health management solutions, and Biologix, a sleeptech startup offering affordable sleep quality assessment tests. Kortex Ventures has also invested in ISA Saúde, a home medical services provider, Sweetch, a personalized lifestyle engagement platform for chronic conditions, Klivo, a chronic patient monitoring platform, and Huna, a startup utilizing artificial intelligence for early cancer identification. Another significant investment is in NeuralMed, a healthtech company focused on using AI to enhance efficiency in the healthcare chain.

The team at Kortex Ventures comprises experienced investors, entrepreneurs, and technologists with extensive backgrounds in high-growth technology companies. Gustavo Cavenaghi serves as the head of the fund, guiding its investment strategy and fostering partnerships with promising startups. The firm's approach emphasizes hands-on and collaborative support, leveraging its ecosystem to empower founders and accelerate the growth of its portfolio companies.